Head to head
Edgewell Personal Care vs Procter & Gamble
Side-by-side on the measures that matter, with a plain-English read. Full detail: EPC · PG
EPC
Edgewell Personal Care
27.49+2.31%
1-year price shape — +40% over the period
Quant Rating B · 79/100
vs
PG
Procter & Gamble
147.82-0.40%
1-year price shape — -0% over the period
Quant Rating C · 40/100
1-year performance, rebased to 100
Procter & Gamble edges it on the scoreable measures. Procter & Gamble pays the highest dividend yield; Procter & Gamble earns the most per share.
| EPC | PG | |
|---|---|---|
| Snapshot | ||
| Sector | -- | -- |
| Last price | 27.49 | 147.82 |
| Change today | +2.31% | -0.40% |
| 1-year return | +39.7% | -0.2% |
| Market cap | $1.27B | $343.34B |
| 52-week range | 15.53 – 29.79 | 134.62 – 164.77 |
| Valuation | ||
| P/E (TTM) | -13.81 | 22.33 |
| P/E percentile, own 5-yr range | 11th | 14th |
| P/B | 0.87 | 6.44 |
| Dividend yield | 2.18% | 2.88% |
| Profitability & growth | ||
| EPS (TTM) | 0.53 | 6.62 |
| Net profit (TTM) | $24.43M | $15.38B |
| Revenue (TTM) | $2.24B | $87.03B |
| Revenue growth (YoY) | +1.7% | +1.5% |
| Gross margin | 39.5% | 50.2% |
| Operating margin | 5.8% | 22.7% |
| Net margin | -4.2% | 18.1% |
| Free cash flow (TTM) | $52.40M | $15.15B |
| Ownership & sentiment | ||
| Institutional ownership | 118.0% | 71.5% |
| Insider activity (12mo) | 26 buy / 20 sell | 33 buy / 17 sell |
| Short interest (% of float) | 9.9% | 1.0% |
| Analyst consensus | 50% buy / 50% hold (6) | 53% buy / 47% hold (17) |
| Analyst price target | $32 (+16%) | $160 (+8%) |
| StockVane view | ||
| StockVane Quant Rating | B (79) | C (40) |
| Company | ||
| Employees | 6,700 | 104,000 |
| Founded | 1999 | 1837 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.